Hemanth Naick Banavath

Hemanth Naick Banavath

Auto-generated profile, based on publicly available information

Hemanth Naick Banavath

Central University of Rajasthan, Rajasthan, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2024 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SGShruti Gupta
Shruti Gupta
HTHarshita Tak
Harshita Tak
KRKhushhal Rathore
Khushhal Rathore
HBHemanth Naick Banavath
Hemanth Naick Banavath
KTKiran Kumar Tejavath
Kiran Kumar Tejavath
Resistance to chemotherapeutics is an eminent cause that leads to search for options that help in diminution of pancreatic ductal adenocarcinoma (PDAC) by overcoming resistance issues. Caffeic acid (CFA), a polyphenol occurring in many dietary foods, is known to show antidiabetic and anticancer properties potential. To unveil the effect of CFA on PDAC, we carried out this research in PDAC cells, following which we checked the combination effect of CFA and chemotherapeutics and pre-sensitization effects of CFA. Multitudinous web-based approaches were applied for identifying CFA targets in PDAC and then getting their interconnections. Subsequently, we manifested CFA effects by in-vitro analysis showing IC50 concentrations of 37.37 and 15.06 µM on Panc-1 and Mia-PaCa-2, respectively. The combination index of CFA with different drugs was explored which showed the antagonistic effects of combination treatment leading to further investigation of the pre-sensitizing effects. CFA pre-sensitization reduced IC50 concentration of doxorubicin in both PDAC cell lines which also triggered ROS generation determined by 2',7'-dichlorofluorescin diacetate assay. The differential gene expression analysis after CFA treatment showed discrete genes affected in both cells, i.e. N-Cad and Cas9 in Panc-1 and Pi3K/AkT/mTOR along with p53 in Mia-PaCa-2. Collectively, this study investigated the role of CFA as PDAC therapeutics and explored the mechanism in mitigating resistance of PDAC by sensitizing to chemotherapeutics.Communicated by Ramaswamy H. Sarma.

19 December 2024 in Journal of Ayurveda and Integrative Medicine
Verified
Journal Article
Open access
SJShalini Jain
Shalini Jain
Mukesh Kumar SharmaMukesh Kumar Sharma
Mukesh Kumar Sharma
NGNidhi Gupta
Nidhi Gupta
JAJivanage Anirudh
Jivanage Anirudh
HBHemanth Naick Banavath
Hemanth Naick Banavath
SCSreemoyee Chatterjee
Sreemoyee Chatterjee
Plant formulations with antidiabetic and antioxidant properties have recently gained popularity due to their lower cost and lesser side effects. Guggul gum is one such formulation that is extensively being used to cure various ailments. The present study was designed to explore the antioxidant and antidiabetic properties of the aqua-ethanolic Guggul gum extract (GE) from Commiphora wightii using in silico studies and in vitro assays. Gas Chromatography Mass Spectroscopy (GCMS) identified compounds were docked to the Human pancreatic α-amylase (HPA, PDB ID: 1HNY) for in silico studies to predict the inhibition. Molecular dynamics simulations (MDS) were performed using GROMACS for 100 ns. The inhibition of the enzyme was further evaluated at in vitro level to show the compounds' hypoglycemic role. The extract showed a good amount of phenolic (5.14 ± 0.011 mg), flavonoid (0.66 ± 0.023 mg) and terpenoid (1.08 ± 0.018 mg) content along with a promising free radical scavenging activity of 41.96 ± 4.02%. In the in silico studies, 3 out of 6 GCMS-identified bioactive compounds showed permissible values of bioavailability properties suggesting them as a potential candidate for antidiabetic drugs. Similarly, in molecular docking studies, 3 compounds showed more binding energy than the standard drug acarbose indicating better inhibition. MDS studies showed Compound 4 (Diisooctyl phthalate), was the most stable with the lowest root mean square deviation (RMSD) and root mean square fluctuation (RMSF) values, a consistent radius of gyration (Rg), and stable solvent accessible surface area (SASA). This was further confirmed by in vitro analysis where the pancreatic α-amylase inhibitory activity of the extract and the standard drug (acarbose) were comparable at an IC50 value of 4.17 ± 1.26 mg/mL and 3.69 ± 0.89 mg/mL respectively. The results demonstrated GE as a potential alternative to commercial antidiabetic drugs. Out of the major 6 GCMS-identified compounds, Compound 4 showed the most stable conformation during MDS studies. However, the isolation of the identified compounds could be done in the future for in vivo studies.

19 August 2026 in International Journal of Sports Medicine
Verified
Journal Article
Closed access
ACArpan Chattopadhyay
Arpan Chattopadhyay
PDPatrick Diel
Patrick Diel
HBHemanth Naick B
Hemanth Naick B
Circulating cell-free mitochondrial DNA has recently gained attention as a sensitive biomarker of physiological stress and adaptation in athletes. Intense exercise challenges mitochondrial function and can lead to the release of circulating cell-free mitochondrial DNA into the circulation, where it acts as a mitochondrial damage-associated molecular pattern. These fragments, recognized by the innate immune system due to their bacterial-like CpG motifs, trigger inflammatory responses and reflect cellular strain. Acute bouts of high-intensity exercise, mechanical stress, or trauma are associated with sharp increases in circulating cell-free mitochondrial DNA levels, while consistent training and regular recovery help maintain lower baseline concentrations, suggesting a role in adaptive regulation. Elevated circulating cell-free mitochondrial DNA levels in athletes have been linked to impaired recovery, increased inflammatory burden, and potential overtraining, whereas controlled exercise appears to facilitate its clearance and contribute to systemic resilience. Beyond physical performance, emerging evidence suggests that circulating cell-free mitochondrial DNA is also linked to psychobiological stress, offering an insight into both the physical and mental demands placed on athletes. Monitoring circulating cell-free mitochondrial DNA dynamics alongside traditional physiological measures such as cortisol, maximal oxygen uptake, and haematological markers could therefore provide a more comprehensive assessment of training load, recovery status, and susceptibility to stress-related disorders. As sports science advances toward precision monitoring, circulating cell-free mitochondrial DNA represents a promising molecular tool for guiding individualized training programs, preventing overtraining, and safeguarding long-term athlete health.